查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032823

嗜中性白血球低下症治療市場報告：治療方法、分銷管道和地區分類（2026-2034 年）

Neutropenia Treatment Market Report by Treatment (Colony-Stimulating Factors, Antibiotics, Antifungals, Antivirals), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2025年全球嗜中性白血球低下症治療市場規模達168億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到254億美元，2026年至2034年的複合年成長率為4.54%。市場成長的主要促進因素是雲端平台的日益普及、智慧型手機銷售的成長以及積極的研發活動。

嗜中性白血球低下症是一種以白血球（WBC）數量異常低為特徵的疾病，白血球是幫助身體抵抗感染疾病。多種因素和疾病都可能導致嗜中性白血球減少症，包括感染疾病、化療、先天性骨髓異常、自體免疫疾病以及某些藥物（藥物嗜中性白血球低下症）。嗜中性白血球在骨髓中產生，骨髓是存在於脊椎、肋骨和骨盆等大骨頭中的海綿狀組織。嗜中性白血球低下症的治療方法包括使用抗生素、抗真菌藥物和抗病毒藥物。這些藥物透過殺死攻擊身體的有害真菌、酵母菌和細菌來幫助抵抗感染疾病。這些藥物可以降低感染疾病風險，並刺激骨髓產生更多白血球。

嗜中性白血球低下症治療市場趨勢：

人們對嗜中性白血球低下症和化療相關副作用的認知不斷提高，是推動市場成長的主要因素。這導致對易於服用的膠囊和片劑口服藥物的需求增加，進一步促進了市場成長。此外，領先企業正積極致力於傳播有關嗜中性白血球低下症預防、早期診斷和有效治療的相關資訊和知識，這也推動了市場成長。大眾對現有治療方案的認知度提高是促進市場成長的另一個因素。此外，製造商正致力於推出經濟實惠的嗜中性白血球低下症治療藥物，進一步促進了市場成長。新型給藥方式的採用提高了患者的便利性，從而提高了用藥依從性，這也對市場成長產生了正面影響。此外，嗜中性白血球低下症藥物的供應日益增加，以及旨在促進和生產生物相似藥的新法規的實施，都為市場帶來了良好的前景。透過註冊網站等線上零售平台便捷地取得藥品也是市場成長要素之一，使患者能夠以實惠的價格訂購和購買藥品。其他預計推動市場成長的因素包括廣泛的研發活動、創新有效藥物的推出、癌症發病率的上升、透過基礎設施建設改善醫療保健設施的可及性、消費者購買力的提高以及政府為促進公眾健康而採取的各種措施。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：嗜中性白血球低下症治療市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依治療方式分類

  • 集落刺激因子
  • 抗生素
  • 抗真菌藥物
  • 抗病毒藥物

第7章 市場區隔：依分銷通路分類

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章：促進、抑制與機遇

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Amgen Inc.
    • BeyondSpring Inc.
    • Kyowa Hakko Kirin Co. Ltd.（Kirin Holdings Company Limited）
    • Pfizer Inc.
    • Sandoz Inc.（Novartis AG）
    • Spectrum Pharmaceuticals Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
Product Code: SR112026A6852

The global neutropenia treatment market size reached USD 16.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4.54% during 2026-2034. The increasing adoption of cloud platforms, escalating sales of smartphones and extensive research and development (R&D) activities represent some of the key factors driving the market.

Neutropenia is a disease characterized by an abnormally low count of white blood cells (WBCs) that help the body fight infections. It is caused by various situations or diseases, including infections, chemotherapy, congenital bone marrow abnormalities, autoimmune disorders, and some medications (drug-induced neutropenia). Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones, such as the vertebrae, ribs, and pelvis. Neutropenia treatment includes antibiotics, antifungals, and antiviral medications that help fight against infection by destroying harmful fungi, yeast , and bacteria that attack the body. These medications assist in reducing the likelihood of infections and stimulate the bone marrow to produce more white blood cells.

NEUTROPENIA TREATMENT MARKET TRENDS:

The rising awareness of neutropenia and chemotherapy-related side effects is one of the key factors driving the market growth. In line with this, the increasing demand for oral drugs that are available in capsule and tablet form and consist of convenient routes of administration is favoring the market growth. Moreover, key players are actively engaged in disseminating relevant information and knowledge regarding preventive measures, early diagnosis, and effective treatment of neutropenia, which, in turn, is propelling the market growth. Furthermore, the increasing awareness among the masses regarding the available treatment alternatives is acting as another growth-inducing factor. In addition to this, manufacturers are focusing on the introduction of cost-effective medicines for neutropenia treatment, which is facilitating the market growth. Additionally, the utilization of novel drug delivery methods that helps in improving patient convenience, which leads to improved patient adherence, is positively influencing the market growth. Besides this, the increase in febrile neutropenia medications and the implementation of new legislation to promote and manufacture biosimilars are creating a positive outlook for the market. The market is also driven by the easy availability of medications through online retail portals, such as registered websites, which provides convenience of ordering and procurement of medications at affordable price-points. Other factors, including extensive research and development (R&D) activities, the introduction of innovative and effective drugs, rising incidences of cancer, easy access to healthcare facilities owing to improved infrastructure, increasing expenditure capacities of consumers and the implementation of various government initiatives for promoting public health, are anticipated to drive the market growth.

KEY MARKET SEGMENTATION:

Treatment Insights:

  • Colony-Stimulating Factors
  • Antibiotics
  • Antifungals
  • Antivirals

Distribution channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for neutropenia treatment. Some of the factors driving the North America neutropenia treatment market included increasing demand for internet-enabled services by enterprises, extensive research and development (R&D) activities, and various technological advancements.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global neutropenia treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amgen Inc., BeyondSpring Inc., Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited), Pfizer Inc., Sandoz Inc. (Novartis AG), Spectrum Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neutropenia Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Treatment

  • 6.1 Colony-Stimulating Factors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Antibiotics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Antifungals
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Antivirals
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Amgen Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BeyondSpring Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
    • 13.3.3 Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Pfizer Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Sandoz Inc. (Novartis AG)
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Spectrum Pharmaceuticals Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Teva Pharmaceutical Industries Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Viatris Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials

List of Figures

  • Figure 1: Global: Neutropenia Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Neutropenia Treatment Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Neutropenia Treatment Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Neutropenia Treatment Market: Breakup by Treatment (in %), 2025
  • Figure 5: Global: Neutropenia Treatment Market: Breakup by Distribution Channel (in %), 2025
  • Figure 6: Global: Neutropenia Treatment Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Neutropenia Treatment (Antibiotics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Neutropenia Treatment (Antibiotics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Neutropenia Treatment (Antifungals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Neutropenia Treatment (Antifungals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Neutropenia Treatment (Antivirals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Neutropenia Treatment (Antivirals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Neutropenia Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Neutropenia Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Neutropenia Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Neutropenia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Neutropenia Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Neutropenia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: North America: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: North America: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: United States: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: United States: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Canada: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Canada: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Asia-Pacific: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Asia-Pacific: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: China: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: China: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Japan: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Japan: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: India: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: India: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: South Korea: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: South Korea: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Australia: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Australia: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Indonesia: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Indonesia: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Others: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Europe: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Europe: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Germany: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Germany: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: France: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: France: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: United Kingdom: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: United Kingdom: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Italy: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Italy: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Spain: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Spain: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Russia: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Russia: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Others: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Latin America: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Latin America: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Brazil: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Brazil: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Mexico: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Mexico: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Middle East and Africa: Neutropenia Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Middle East and Africa: Neutropenia Treatment Market: Breakup by Country (in %), 2025
  • Figure 69: Middle East and Africa: Neutropenia Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Global: Neutropenia Treatment Industry: Drivers, Restraints, and Opportunities
  • Figure 71: Global: Neutropenia Treatment Industry: Value Chain Analysis
  • Figure 72: Global: Neutropenia Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neutropenia Treatment Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Neutropenia Treatment Market Forecast: Breakup by Treatment (in Million USD), 2026-2034
  • Table 3: Global: Neutropenia Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 4: Global: Neutropenia Treatment Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Neutropenia Treatment Market: Competitive Structure
  • Table 6: Global: Neutropenia Treatment Market: Key Players